Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001316191 | SCV001506796 | uncertain significance | not provided | 2018-07-24 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine with serine at codon 1152 of the IKBKAP protein (p.Gly1152Ser). The glycine residue is weakly conserved and there is a small physicochemical difference between glycine and serine. This variant is present in population databases (rs771838754, ExAC 0.04%). This variant has not been reported in the literature in individuals with IKBKAP-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002495083 | SCV002776333 | uncertain significance | Medulloblastoma; Familial dysautonomia | 2022-04-19 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000802774 | SCV001461185 | uncertain significance | Familial dysautonomia | 2020-03-17 | no assertion criteria provided | clinical testing |